BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Marinus Pharmaceuticals Presents Clinical Data Of Ganaxolone In Pediatric Epilepsies At Antiepileptic Drug And Device Trials XIII Conference

  May 18, 2015

   · 

  7 min read
• Drug Development

  Portola Pharmaceuticals, Inc. Announces Upcoming Data Presentation On Dual Kinase Inhibitor Cerdulatinib At ASCO Annual Meeting

  May 18, 2015

   · 

  7 min read
• Drug Development

  XBiotech USA Secures Approval From Data Safety Monitoring Board To Continue Phase III Registration Study In Europe For Its Novel Cancer Immunotherapy

  May 18, 2015

   · 

  3 min read
• Business

  TissueGene, Inc. Announces Special Protocol Assessment (SPA) Agreement With The FDA For Its Phase 3 Clinical Trial Of Invossa For Patients Suffering From Osteoarthritis Of The Knee

  May 18, 2015

   · 

  3 min read
• Pharm Country

  Philips Response To ResMed Update On Phase IV SERVE-HF Study Of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea And Chronic Heart Failure

  May 18, 2015

   · 

  2 min read
• Endo International Announces Updated XIAFLEX Label With Recurrence And Retreatment Data In Patients With Dupuytren’s Contracture

  May 18, 2015

   · 

  11 min read
• Drug Development

  Astellas Pharma US Release: Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial

  May 18, 2015

   · 

  8 min read
• Drug Development

  Sangamo BioSciences Presents New Data From Proprietary ZFP Therapeutic Programs For Lysosomal Storge Disorders At Annual Meeting Of The American Society Of Gene And Cell Therapy

  May 18, 2015

   · 

  6 min read
• Actavis Launches NAMZARIC (memantine hydrochloride Extended-Release And donepezil hydrochloride), A Fixed-Dose Combination Therapy For The Treatment Of Moderate To Severe Alzheimer’s Disease

  May 18, 2015

   · 

  9 min read
• Biotech Bay

  The New England Journal of Medicine Publishes Study Results Suggesting Veracyte, Inc.'s Percepta Bronchial Genomic Classifier Can Reduce Unnecessary Invasive Procedures In Lung Cancer Diagnosis

  May 18, 2015

   · 

  11 min read